TickerGuard
Buy Day today: Neutral (58) Mixed market breadth · no major macro event
TEVA

Teva Pharma Industries Ltd

Healthcare · Drug Manufacturers - Specialty & Generic

36.80$ +0.7% vs. previous close Closing price · As of: Aug 14, 2026

Statements

Ratios

Valuation ratios (P/E, P/S, EV/EBITDA and the other multiples) are based on the closing price at the end of each period, not on the current price. Margins and returns are shown in percent, multiples without a unit, per-share figures in the reporting currency, net debt in millions.

Tick rows to compare them in a chart (up to 4)

Ratios TEVA
Line item Q3 16 Q4 16 Q1 17 Q2 17 Q3 17 Q4 17 Q1 18 Q2 18 Q3 18 Q4 18 Q1 19 Q2 19 Q3 19 Q4 19 Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
Valuation
27.1 185.1 156.2 3,382.5 14.8 21.2 33.0 26.0 22.7 56.7
2.2 1.7 1.4 1.4 0.8 0.9 0.8 1.2 1.1 0.8 0.9 0.6 0.4 0.6 0.6 0.8 0.6 0.6 0.8 0.7 0.7 0.6 0.7 0.5 0.6 0.7 0.7 0.6 0.8 0.7 1.0 1.1 1.2 1.5 1.1 1.2 1.4 2.1 2.0 2.3
1.3 1.1 1.0 1.2 0.6 1.1 0.9 1.4 1.2 1.1 1.2 0.7 0.5 0.8 0.7 1.0 1.0 1.1 1.3 1.1 1.0 0.9 1.1 0.9 1.0 1.3 1.3 1.2 1.7 1.6 2.2 2.9 3.4 4.6 2.9 2.9 3.2 4.6 4.3 5.2
4.0 3.3 2.9 2.9 2.2 2.3 2.1 2.5 2.5 2.3 2.4 2.1 1.9 2.1 2.0 2.2 2.0 2.1 2.2 2.1 2.0 1.9 2.0 1.8 1.9 1.9 1.9 1.8 1.9 1.8 2.0 2.1 2.1 2.4 2.0 2.1 2.3 2.9 2.8 3.1
17.3 23.1 22.1 48.5 19.5 18.5 14.4 8.4 10.0 17.3 14.8 17.5 36.0 14.5 13.7 16.2 7.3 10.3 14.3 17.8 23.6 12.8 11.6 9.8 14.9 14.8 20.4
9.8 8.5 9.6 10.7 6.4 7.3 4.7 7.8 8.6 8.8 38.1 119.6 48.1 23.9 15.1 10.9 16.8 122.2 37.4 17.8 17.5 17.6 9.7 10.3 7.2 19.0 14.0 18.0 27.2 14.9 33.3 23.3 21.9 40.7 31.9 30.3 29.7
10.2% 11.7% 10.4% 9.3% 15.7% 13.6% 21.2% 12.8% 11.7% 11.3% 2.6% 0.8% -0.6% 2.1% 4.2% 6.6% 9.1% 5.9% -0.7% -1.2% 0.8% 2.7% 5.6% 5.7% 5.7% 10.3% 9.7% 14.0% 5.3% 7.1% 5.5% 3.7% 6.7% 3.0% 4.3% 4.6% 2.5% 3.1% 3.3% 3.4%
Margins
55.8% 54.1% 52.3% 50.6% 49.8% 48.4% 47.5% 46.0% 45.4% 44.6% 43.7% 43.7% 43.2% 43.4% 44.4% 44.9% 45.8% 46.4% 46.3% 46.9% 46.8% 47.8% 47.9% 47.8% 47.9% 46.7% 45.7% 45.4% 45.8% 48.2% 49.0% 49.5% 49.8% 48.7% 49.2% 49.6% 50.1% 51.8% 52.1% 52.5%
15.9% 9.8% 8.3% -18.0% -19.7% -78.1% -77.2% -53.4% -58.2% -8.7% -16.7% -20.6% -21.5% -2.6% -2.2% 2.5% -23.0% -21.4% -20.4% -17.9% 12.6% 10.8% 3.7% -6.2% -7.7% -14.1% -9.4% -7.3% -7.7% 2.7% 1.4% 5.4% 2.9% -1.8% 2.6% 5.4% 10.9% 12.5% 13.2% 11.5%
8.2% 0.9% 0.9% -25.7% -24.9% -73.2% -73.0% -48.6% -55.0% -11.7% -18.7% -21.9% -22.9% -5.8% -4.7% 0.0% -24.2% -24.0% -24.5% -24.0% 4.5% 2.6% -4.0% -6.8% -8.5% -15.8% -10.8% -15.0% -14.7% -3.5% -3.0% -2.8% -5.7% -9.9% -7.7% -1.0% 4.2% 8.2% 9.0% 4.1%
22.7% 19.7% 14.9% 13.5% 12.0% 11.8% 16.9% 15.2% 12.9% 9.5% 2.5% 0.5% -0.2% 1.3% 2.4% 5.3% 5.4% 3.8% -0.6% -0.8% 0.5% 1.5% 3.8% 3.1% 3.4% 7.0% 6.5% 7.8% 4.0% 5.3% 5.5% 4.2% 8.2% 4.5% 4.6% 5.4% 3.4% 6.7% 6.8% 7.8%
Returns
4.8% 0.6% 0.6% -21.5% -20.3% -94.4% -85.5% -56.4% -61.3% -15.1% -22.9% -27.5% -29.0% -7.2% -6.1% 0.0% -42.0% -39.8% -39.8% -37.9% 6.9% 4.1% -6.6% -11.7% -14.7% -30.1% -20.6% -32.0% -32.4% -7.5% -6.6% -7.1% -15.8% -30.5% -20.5% -2.3% 9.8% 17.8% 19.0% 9.1%
1.7% 0.2% 0.2% -7.0% -6.8% -23.2% -23.0% -15.1% -16.7% -3.7% -5.6% -6.5% -7.0% -1.7% -1.5% 0.0% -8.1% -7.9% -8.1% -8.0% 1.5% 0.9% -1.3% -2.3% -2.9% -5.3% -3.7% -5.2% -5.3% -1.3% -1.1% -1.1% -2.3% -4.2% -3.3% -0.4% 1.8% 3.5% 3.9% 1.8%
Balance Sheet & Debt
35,298 34,812 33,736 34,453 34,022 31,512 29,334 28,376 27,614 27,134 26,765 26,681 25,817 24,932 24,299 23,863 23,794 23,742 23,242 22,696 21,702 20,878 20,742 20,024 19,041 18,411 18,548 18,009 17,725 16,607 16,653 16,383 15,661 14,483 14,954 15,066 14,587 13,250 12,886 12,937
7.6 11.2 11.2 30.6 13.6 13.2 9.2 5.6 7.0 11.5 10.5 11.8 23.2 9.4 9.4 9.8 4.2 5.3 6.7 7.7 8.7 5.8 5.1 3.8 4.0 3.9 5.0
35.6% 35.9% 37.3% 32.4% 33.3% 24.6% 26.9% 26.8% 27.3% 24.2% 24.6% 23.8% 24.1% 24.3% 24.5% 25.2% 19.3% 19.8% 20.4% 21.0% 21.9% 21.6% 19.9% 19.7% 19.8% 17.7% 18.1% 16.4% 16.5% 17.3% 17.0% 15.4% 14.5% 13.7% 16.3% 17.0% 18.2% 19.4% 20.5% 19.5%
1.0 1.1 1.0 1.3 1.2 1.9 1.7 1.7 1.7 2.0 2.0 2.0 2.0 1.9 1.9 1.9 2.7 2.6 2.5 2.4 2.3 2.2 2.5 2.4 2.4 2.7 2.6 2.9 2.9 2.6 2.7 2.9 3.1 3.3 2.7 2.5 2.3 2.1 2.0 2.1
Per Share
1.70 0.20 0.21 -5.91 -5.74 -16.12 -15.61 -9.95 -10.67 -2.15 -3.10 -3.56 -3.66 -0.91 -0.75 0.00 -3.68 -3.60 -3.60 -3.53 0.65 0.38 -0.56 -0.95 -1.15 -2.12 -1.45 -2.02 -1.98 -0.49 -0.43 -0.40 -0.85 -1.45 -1.11 -0.14 0.61 1.20 1.33 0.60
20.62 21.58 22.34 22.98 23.03 22.01 21.39 20.47 19.40 18.29 16.59 16.23 15.98 15.87 15.90 15.42 15.21 15.05 14.71 14.72 14.64 14.40 14.05 13.90 13.53 13.43 13.39 13.41 13.46 13.94 14.25 14.38 14.80 14.60 14.34 14.32 14.41 14.71 14.71 14.66
35.70 32.84 33.45 27.53 28.19 17.07 18.26 17.62 17.42 14.26 13.52 12.93 12.63 12.77 12.35 12.59 8.75 9.06 9.03 9.31 9.44 9.32 8.44 8.14 7.83 7.02 7.05 6.30 6.10 6.60 6.48 5.61 5.35 4.74 5.40 5.88 6.23 6.74 6.98 6.57
4.67 4.26 3.33 3.10 2.77 2.59 3.63 3.12 2.51 1.74 0.41 0.08 -0.04 0.20 0.38 0.81 0.82 0.58 -0.08 -0.12 0.08 0.21 0.53 0.43 0.46 0.94 0.86 1.05 0.54 0.74 0.78 0.60 1.21 0.66 0.66 0.77 0.50 0.98 0.99 1.14

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: August 14, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?